These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 22693244)

  • 1. Prediction of outcomes for patients with brain parenchymal metastases from breast cancer (BC): a new BC-specific prognostic model and a nomogram.
    Ahn HK; Lee S; Park YH; Sohn JH; Jo JC; Ahn JH; Jung KH; Park S; Cho EY; Lee JI; Park W; Choi DH; Huh SJ; Ahn JS; Kim SB; Im YH
    Neuro Oncol; 2012 Aug; 14(8):1105-13. PubMed ID: 22693244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Breast cancer patients with brain metastases or leptomeningeal disease: 10-year results of a national cohort with validation of prognostic indexes.
    Znidaric T; Gugic J; Marinko T; Gojkovic Horvat A; Paulin Kosir MS; Golo D; Ivanetic Pantar M; Ratosa I
    Breast J; 2019 Nov; 25(6):1117-1125. PubMed ID: 31286623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new nomogram for estimating survival in patients with brain metastases secondary to colorectal cancer.
    Pietrantonio F; Aprile G; Rimassa L; Franco P; Lonardi S; Cremolini C; Biondani P; Sbicego EL; Pasqualetti F; Tomasello G; Niger M; Casagrande M; Ghidini M; Muni R; Montrone S; Bergamo F; Berenato R; Fontanella C; Bozzarelli S; Moretto R; Battaglin F; Di Bartolomeo M; de Braud F; Miceli R
    Radiother Oncol; 2015 Nov; 117(2):315-21. PubMed ID: 26347495
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: extra-cranial disease progression is an independent risk factor.
    Zhuang Q; Wong RX; Lian WX; Li YQ; Wong FY
    Ann Palliat Med; 2019 Sep; 8(4):390-400. PubMed ID: 30943738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. External validation of a published nomogram for prediction of brain metastasis in patients with extra-cerebral metastatic breast cancer and risk regression analysis.
    Genre L; Roché H; Varela L; Kanoun D; Ouali M; Filleron T; Dalenc F
    Eur J Cancer; 2017 Feb; 72():200-209. PubMed ID: 28042991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. External validation of Modified Breast Graded Prognostic Assessment for breast cancer patients with brain metastases: A multicentric European experience.
    Griguolo G; Jacot W; Kantelhardt E; Dieci MV; Bourgier C; Thomssen C; Bailleux C; Miglietta F; Braccini AL; Conte P; Ferrero JM; Guarneri V; Darlix A
    Breast; 2018 Feb; 37():36-41. PubMed ID: 29073498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new nomogram and risk classification system for predicting survival in small cell lung cancer patients diagnosed with brain metastasis: a large population-based study.
    Shan Q; Shi J; Wang X; Guo J; Han X; Wang Z; Wang H
    BMC Cancer; 2021 May; 21(1):640. PubMed ID: 34051733
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival time following resection of intracranial metastases from NSCLC-development and validation of a novel nomogram.
    Ji X; Zhuang Y; Yin X; Zhan Q; Zhou X; Liang X
    BMC Cancer; 2017 Nov; 17(1):774. PubMed ID: 29157203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain Metastases.
    Subbiah IM; Lei X; Weinberg JS; Sulman EP; Chavez-MacGregor M; Tripathy D; Gupta R; Varma A; Chouhan J; Guevarra RP; Valero V; Gilbert MR; Gonzalez-Angulo AM
    J Clin Oncol; 2015 Jul; 33(20):2239-45. PubMed ID: 25987700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting survival in women with breast cancer and brain metastasis: a nomogram outperforms current survival prediction models.
    Marko NF; Xu Z; Gao T; Kattan MW; Weil RJ
    Cancer; 2012 Aug; 118(15):3749-57. PubMed ID: 22180078
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
    Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
    World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Validation and comparison of Breast Graded Prognostic Assessment scores in patients with breast cancer and brain metastases.
    Fabregat-Franco C; Stradella A; Navarro V; Linares J; Galdeano M; Recalde S; Velasco R; Simo M; Fernadez A; Venthecourt AC; Falo C; Vazquez S; Bergamino M; Villanueva R; Pernas S; Gil-Gil MJ
    Clin Transl Oncol; 2021 Sep; 23(9):1761-1768. PubMed ID: 33704689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of graded prognostic assessment for breast Cancer brain metastasis incorporating extracranial metastatic features: a retrospective analysis of 284 patients.
    Wang Y; Xu H; Sa Q; Li L; Han Y; Wu Y; Zhou Y; Xu B; Wang J
    BMC Cancer; 2024 Oct; 24(1):1262. PubMed ID: 39390441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors, prognostic factors, and nomograms for bone metastasis in patients with newly diagnosed infiltrating duct carcinoma of the breast: a population-based study.
    Huang Z; Hu C; Liu K; Yuan L; Li Y; Zhao C; Hu C
    BMC Cancer; 2020 Nov; 20(1):1145. PubMed ID: 33238981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of tumor subtype on survival and the graded prognostic assessment for patients with breast cancer and brain metastases.
    Sperduto PW; Kased N; Roberge D; Xu Z; Shanley R; Luo X; Sneed PK; Chao ST; Weil RJ; Suh J; Bhatt A; Jensen AW; Brown PD; Shih HA; Kirkpatrick J; Gaspar LE; Fiveash JB; Chiang V; Knisely JP; Sperduto CM; Lin N; Mehta M
    Int J Radiat Oncol Biol Phys; 2012 Apr; 82(5):2111-7. PubMed ID: 21497451
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Survival outcomes of breast cancer patients with brain metastases: A multicenter retrospective study in Korea (KROG 16-12).
    Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Nam JH; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
    Breast; 2020 Feb; 49():41-47. PubMed ID: 31677532
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Individualized early death and long-term survival prediction after stereotactic radiosurgery for brain metastases of non-small cell lung cancer: Two externally validated nomograms.
    Zindler JD; Jochems A; Lagerwaard FJ; Beumer R; Troost EGC; Eekers DBP; Compter I; van der Toorn PP; Essers M; Oei B; Hurkmans CW; Bruynzeel AME; Bosmans G; Swinnen A; Leijenaar RTH; Lambin P
    Radiother Oncol; 2017 May; 123(2):189-194. PubMed ID: 28237400
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characteristics and Prognostic Factors for Patients With HER2-overexpressing Breast Cancer and Brain Metastases in the Era of HER2-targeted Therapy: An Argument for Earlier Detection.
    Morikawa A; Wang R; Patil S; Diab A; Yang J; Hudis CA; McArthur HL; Beal K; Seidman AD
    Clin Breast Cancer; 2018 Oct; 18(5):353-361. PubMed ID: 29337140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.
    Graesslin O; Abdulkarim BS; Coutant C; Huguet F; Gabos Z; Hsu L; Marpeau O; Uzan S; Pusztai L; Strom EA; Hortobagyi GN; Rouzier R; Ibrahim NK
    J Clin Oncol; 2010 Apr; 28(12):2032-7. PubMed ID: 20308667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nomogram for Predicting the Overall Survival of Patients With Breast Cancer With Pathologic Nodal Status N3.
    Wang J; Chen L; Nie Y; Wu W; Yao Y
    Clin Breast Cancer; 2020 Dec; 20(6):e778-e785. PubMed ID: 32636150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.